Reporting owner · Q3 2026 · CIK 1030575

Formela Jean Francois: insider trades.

Formela Jean Francois reported 14 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 14 sales ($2.7M), across 1 company.

Transactions
14
Purchases (P)
0
Sales (S)
14
Companies
1
Name as filed
FORMELA JEAN FRANCOIS

Companies

CompanyRelationshipTransactions
Korro Bio, Inc. (KRRO)Director14

Transactions

14 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-14Korro Bio, Inc.S31,888$14.12640,610Form 4
2026-09-14Korro Bio, Inc.S6,602$14.12132,650Form 4
2026-09-11Korro Bio, Inc.S1,750$13.99139,252Form 4
2026-09-11Korro Bio, Inc.S8,450$13.99672,498Form 4
2026-08-26Korro Bio, Inc.S249$13.96680,948Form 4
2026-08-26Korro Bio, Inc.S51$13.96141,002Form 4
2026-08-19Korro Bio, Inc.S23,584$14681,197Form 4
2026-08-19Korro Bio, Inc.S4,884$14141,053Form 4
2026-08-11Korro Bio, Inc.S1,775$13.96704,781Form 4
2026-08-11Korro Bio, Inc.S368$13.96145,937Form 4
2026-07-06Korro Bio, Inc.S817$13.96706,556Form 4
2026-07-06Korro Bio, Inc.S8,506$13.96146,305Form 4
2026-07-02Korro Bio, Inc.S85,955$14.03707,373Form 4
2026-07-02Korro Bio, Inc.S14,745$14.03154,811Form 4

Questions

What stock did Formela Jean Francois buy or sell?

Formela Jean Francois reported 14 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 14 sales ($2.7M), across 1 company.

Is Formela Jean Francois the same person as other filers with this name?

This page covers SEC CIK 1030575 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/formela-jean-francois-1030575.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.